Drug Shortage Report for MINT-CITALOPRAM
Report ID | 131327 |
Drug Identification Number | 02429705 |
Brand name | MINT-CITALOPRAM |
Common or Proper name | Citalopram |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottle |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2021-01-11 |
Estimated end date | 2021-03-31 |
Actual end date | 2021-06-21 |
Shortage status | Resolved |
Updated date | 2021-06-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-01-11 | English | Compare |
v2 | 2021-01-11 | French | Compare |
v3 | 2021-01-12 | English | Compare |
v4 | 2021-06-21 | English | Compare |
v5 | 2021-06-21 | French | Compare |
v6 | 2021-06-22 | English | Compare |
Showing 1 to 6 of 6